LEADING THE
HEMMORRHAGE
CONTROL
MARKET

Z-Medica, a leader in hemorrhage control, works tirelessly to develop innovative products and solutions.

With a relentless concentration on smart growth and product development, Z-Medica is focused on hemorrhage control for healthcare providers, military personnel, first responders, and consumers around the world.


GUIDED BY EXPERIENCE AND EXPERTISE

Z-Medica has assembled an experienced management team to bring its innovative bleeding control products to market around the world.
 

EXECUTIVE  TEAM

STEPHEN J.
FANNING

President & Chief Executive Officer
 

FULL BIO

DAVID M.
DEAN

Chief Operating & Financial Officer
 

FULL BIO

DINA
DUBEY

Executive Vice President | Corporate Development

FULL BIO

LEADERSHIP TEAM

JOSEPH M.
AZARY

Vice President | Quality Assurance & International Regulatory Affairs

FULL BIO

DANIEL J.
BURNS

Vice President | Manufacturing
 

FULL BIO

DAVID J.
CLARKE

Vice President | US Healthcare Sales
 

FULL BIO

SCOTT A.
GARRETT

Vice President | Global Military / Tactical Programs & International Healthcare Sales

FULL BIO

MANNY C.
MONTOYA

Vice President | Corporate Accounts
 

FULL BIO

MELINDA M.
POLSON

Vice President | Finance / Controller
 

FULL BIO


A CLEAR VISION ENABLED BY A FOCUSED PLAN

For more than a decade, Z-Medica has saved lives and improved medical outcomes by developing new tools to control bleeding.


Today, Z-Medica builds on its market leadership with ongoing research, product enhancements, brand building, and customer insights. With customers worldwide and ongoing investment, Z-Medica is solidifying its position as a hemorrhage control brand of choice.


POSITIONED AND FUNDED FOR GROWTH

DW Healthcare Partners (DWHP) is Z-Medica’s majority shareholder. DWHP is a healthcare-focused private equity firm dedicated to identifying, nurturing, and growing ideas and companies.

With DWHP’s investment, Z-Medica has focused on new and innovative products, research and development, growing its sales team, and establishing an international presence.


MORE THAN A DECADE OF INVENTION
AND CATEGORY LEADERSHIP

Z-Medica was founded in 2002 after Apollo Space Program Engineer Frank Hursey discovered a novel hemostatic agent. Mr. Hursey saw the potential value of his discovery and partnered with Bart Gullong to ensure that this innovation was in the hands of anyone who could use it to save lives.

While new and revolutionary products have replaced the original zeolite granular product, the desire to bring leading-edge hemostatic innovation to the world remains.

As testament to QuikClot’s efficacy, the US Department of Defense’s Committee on Tactical Combat Casualty Care (CoTCCC) recommends QuikClot Combat Gauze® as the hemostatic dressing of choice for compressible hemorrhage not amenable to tourniquet use.1

  1. The Committee on Tactical Combat Casualty Care. Tactical Combat Casualty Care Guidelines. http://cotccc.com/wp-content/uploads/TCCC- Guidelines-for-Medical-Personnel-170131.pdf. Published January 31, 2017. Accessed March 31, 2017.

Leaving Z-Medica.com

Our site includes links to third party sites in which the Z-Medica® Privacy Policy and Terms of Use do not apply. Please read the privacy policy for every third party website you visit.

Close Continue Close